Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0ZX2D
|
||||
Former ID |
DIB006154
|
||||
Drug Name |
11C-6-Me-BTA-1
|
||||
Synonyms |
Carbon-11-6-Me-BTA-1; 11C-BTA-1
|
||||
Indication | Alzheimer disease [ICD9: 331; ICD10:G30] | Phase 1 | [525385] | ||
Company |
University of Pittsburgh
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
c1(nc2c(s1)cc(cc2)C)c1ccc(N[11CH3])cc1
|
||||
CAS Number |
CAS 370099-48-2
|
||||
Target and Pathway | |||||
Target(s) | Amyloid beta A4 protein | Target Info | Modulator | [529223] | |
KEGG Pathway | Notch signaling pathway | ||||
Alzheimer's disease | |||||
Reactome | Nuclear signaling by ERBB4 | ||||
Degradation of the extracellular matrix | |||||
Regulated proteolysis of p75NTR | |||||
NRIF signals cell death from the nucleus | |||||
Activated NOTCH1 Transmits Signal to the Nucleus | |||||
Constitutive Signaling by NOTCH1 PEST Domain Mutants | |||||
Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | |||||
EPH-ephrin mediated repulsion of cells | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.